- Giá
- $258.92
- Giá trị hợp lý
- $109.62
- Giá trị tiềm năng
- $137.20
- Tính đến
- 2026-09-08
Analog-led demand is the clearest opportunity because Analog was the dominant FY2025 segment.
Capex-to-depreciation remains above 1.5x in FY2030.
Phân tích sản phẩm tùy chọn
Khi được bạn cho phép, chúng tôi sử dụng phân tích giới hạn, chú trọng quyền riêng tư để hiểu hành trình nghiên cứu nào hiệu quả. Chúng tôi không dùng trình theo dõi quảng cáo hoặc ghi lại phiên. Bạn có thể thay đổi lựa chọn này trong Tùy chọn. Đọc Chính sách quyền riêng tư.
Analog-led demand is the clearest opportunity because Analog was the dominant FY2025 segment.
Capex-to-depreciation remains above 1.5x in FY2030.
Sell. At the September 8, 2026 report-date price of $258.92, the shares exceed Fair value of $109.62 and Potential value of $137.20.3
The main risk is that heavy factory investment fails to produce enough demand or margin. Reinvestment would remain high, delaying stronger free cash flow and weakening value per share.45
The clearest upside is an Analog-led recovery that fills the added capacity. If capital spending also normalizes, sales, profit, and free cash flow could improve together.
FY2027 analyst forecasts average $24.93 billion of revenue, supporting a demand-led recovery if customers rebuild orders and Analog participates.1
Sell because the report-date price stands well above Fair value, while capital conversion remains unproven.34
FY2027 analyst forecasts average $24.93 billion of revenue, supporting a demand-led recovery if customers rebuild orders and Analog participates.1
Sell because the report-date price stands well above Fair value, while heavy factory investment has not yet produced enough free cash flow to support that valuation.345
TEXAS INSTRUMENTS INCORPORATED designs and manufacture semiconductors that the company sells to electronics designers and manufacturers all over the world. Its operations began in 1930, and the company is incorporated in Delaware. With headquarters in Dallas, Texas, the company has design, manufacturing or sales operations in more than 30 countries.
Its Analog segment includes the following major product lines: Power and Signal Chain. Its Embedded Processing segment includes microcontrollers, processors, wireless connectivity and radar products. Microcontrollers are self-contained systems with a processor core, memory and peripherals that are designed to control a set of specific tasks for electronic equipment and often integrate analog functionality.
Customer Number One supplied 12% of FY2025 revenue. A loss, repricing, or in-sourcing event would reduce sales and factory use together.
This path would reduce sales, margin, earnings, and free cash flow together. It is disconfirmed by sustained Analog growth, improving margins, and lower capital intensity.
If GAAP operating margin stays below 30% for two fiscal years after FY2027, weak utilization or pricing would impair earnings and cash flow.
If FY2030 capex-to-depreciation remains above 1.5x, reinvestment stays high and dividend coverage remains structurally weak.
Năm diễn biến có thể làm suy yếu luận điểm đầu tư của chúng tôi.
Persistent weak profitability would show that added factories remain underused or pricing has weakened, reducing operating earnings and free cash flow.
Hiện tại:34.06% in FY2025
Cảnh báo nếuBelow 30% for two consecutive fiscal years after FY2027
Switching costs, software integration, distribution reach, and installed-base advantages remain unknown here. Profitability and accounting outcomes do not show whether customers face barriers to switching.
The peer group is only a cross-check because its growth, margins, and valuations vary widely. Even so, lower pricing or lost business could reduce factory use and profit margins.
FY2025 operating income was $6.02 billion on $17.68 billion of revenue. Those results show profitability, but they do not by themselves prove durable pricing power.5
Each lens answers a different valuation question. Only included lenses set Fair value; floors and diagnostics provide context.
Apply a terminal P/E to the dated forward path, then discount that future share value back to the analysis date.
None of the valuation methods used to calculate Fair value relies on a separate assumption about how long the competitive advantage lasts.
The highlighted cell is Fair value when every assumption sits at its base level ($109.62). Each row and column shows what Fair value becomes when one assumption moves.
Free cash flow to the firm stays positive in the first projected year at $4.0B after modeled reinvestment of $2.5B, with terminal value at 52.0% of enterprise value. A sudden drop in free cash flow is not projected unless capital spending relative to revenue, reinvestment, or gross margin resets materially.
The path is supported if FY2027 revenue and diluted EPS remain within their dated forecast ranges. Results below those ranges would weaken the expected recovery.1
This combination would show that the revenue recovery is reaching profit and cash rather than being absorbed by continued heavy investment.
Meeting forecasts would support the expected recovery, but continued heavy capital spending relative to free cash flow would leave the investment burden unresolved.
Lower revenue would weaken the recovery. Falling operating income or free cash flow would show that less profit and cash are reaching shareholders.
The wide FY2027 revenue and diluted-EPS ranges show meaningful outcome uncertainty.1
Growth must absorb factory costs and support consolidated profit.6
FY2025 free cash flow was $2.60 billion against $4.55 billion of capex. Cash improvement depends on utilization lifting profit while spending moves toward maintenance needs.45
The build remains the central allocation decision. If capex-to-depreciation stays at or above 1.5x in FY2030, reinvestment should remain elevated and cash available to shareholders would be lower.
The dated evidence does not establish a comparable return-on-capital trajectory. The added capacity must still demonstrate that revenue and profit can justify the investment.
The relevant hurdle is the 9.8508% WACC calculated as of and retrieved on 2026-09-09.
FY2025 operating cash flow was $7.15 billion, while free cash flow was $2.60 billion.
Stronger value requires lower reinvestment or better operating returns from the added capacity.
Capex fell from $5.07 billion in FY2023 to $4.82 billion in FY2024 and $4.55 billion in FY2025.
The decline makes normalization plausible, but it does not prove that the new assets are earning adequate returns.
| Doanh thu | 17.682.000.000 US$ |
|---|---|
| Giá vốn doanh thu | 7.599.000.000 US$ |
| Lợi nhuận gộp | 10.083.000.000 US$ |
| Chi phí hoạt động | 4.060.000.000 US$ |
| Lợi nhuận hoạt động | 6.023.000.000 US$ |
| Các khoản ngoài hoạt động và thuế | -1.022.000.000 US$ |
| Lợi nhuận ròng | 5.001.000.000 US$ |
| Tổng tài sản | 34.585.000.000 US$ |
|---|---|
| Tiền mặt | 3.225.000.000 US$ |
| Tài sản ngắn hạn | 13.750.000.000 US$ |
| Tổng nợ phải trả | 18.312.000.000 US$ |
| Nợ ngắn hạn | 3.159.000.000 US$ |
| Vốn chủ sở hữu | 16.273.000.000 US$ |
| Lợi nhuận ròng | 5.001.000.000 US$ |
|---|---|
| Dòng tiền vào từ hoạt động | 7.419.000.000 US$ |
| Khấu hao và phân bổ | 1.999.000.000 US$ |
| Thù lao bằng cổ phiếu | 419.000.000 US$ |
| Dòng tiền hoạt động | 7.153.000.000 US$ |
| Dòng tiền ra từ hoạt động | 266.000.000 US$ |
| Tiền sẵn có | 10.353.000.000 US$ |
| Tiền đầu kỳ | 3.200.000.000 US$ |
| Dòng tiền ra từ đầu tư | 1.439.000.000 US$ |
| Dòng tiền ra từ tài chính | 5.689.000.000 US$ |
| Tiền cuối kỳ | 3.225.000.000 US$ |
| Dòng tiền đầu tư | -1.439.000.000 US$ |
| Dòng tiền tài chính | -5.689.000.000 US$ |
Nguồn: SEC EDGAR · Nộp ngày 2026-02-06 · SEC EDGAR
| Doanh thu theo phân khúc hoạt động | Doanh thu | Tỷ trọng | so với cùng kỳ |
|---|---|---|---|
| Analog | 14 T US$ | 79,2% | 15,2% |
| Embedded Processing | 2,7 T US$ | 15,3% | 6,5% |
| All Other Segments | 979 Tr US$ | 5,5% | 3,4% |
Dữ liệu tài chính tại thời điểm được dùng trong phân tích ngày 2026-09-09.
| Kỳ | Doanh thu | EBITDA | Lợi nhuận ròng | Dòng tiền hoạt động | Dòng tiền tự do | Capex | Khấu hao và phân bổ | Thù lao bằng cổ phiếu | Mua lại cổ phiếu | Cổ tức đã trả | Phát hành nợ ròng | Dòng tiền đầu tư | Dòng tiền tài chính | Tiền đầu kỳ | Tiền cuối kỳ | Tiền mặt và đầu tư | Tổng nợ | Biên hoạt động | ROIC | WACC | Chênh lệch ROIC−WACC |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | 13,4 T US$ | 6 T US$ | 3,6 T US$ | 4,6 T US$ | 4,1 T US$ | 531 Tr US$ | 955 Tr US$ | 252 Tr US$ | 2,1 T US$ | 1,6 T US$ | — | -650 Tr US$ | -3,8 T US$ | — | 1,2 T US$ | 3,5 T US$ | 3,6 T US$ | 36,3% | — | — | — |
| 2017-12-31 | 15 T US$ | 7,1 T US$ | 3,7 T US$ | 5,4 T US$ | 4,7 T US$ | 695 Tr US$ | 904 Tr US$ | 242 Tr US$ | 2,6 T US$ | 2,1 T US$ | — | -1,1 T US$ | -3,7 T US$ | 1,2 T US$ | 1,7 T US$ | 4,5 T US$ | 4,1 T US$ | 40,7% | — | — | — |
| 2018-12-31 | 15,8 T US$ | 7,8 T US$ | 5,6 T US$ | 7,2 T US$ | 6,1 T US$ | 1,1 T US$ | 954 Tr US$ | 232 Tr US$ | 5,1 T US$ | 2,6 T US$ | — | -78 Tr US$ | -6,3 T US$ | 1,7 T US$ | 2,4 T US$ | 4,2 T US$ | 5,1 T US$ | 42,5% | — | — | — |
| 2019-12-31 | 14,4 T US$ | 6,9 T US$ | 5 T US$ | 6,6 T US$ | 5,8 T US$ | 847 Tr US$ | 1,1 T US$ | 217 Tr US$ | 3 T US$ | 3 T US$ | — | -1,9 T US$ | -4,7 T US$ | 2,4 T US$ | 2,4 T US$ | 5,4 T US$ | 5,8 T US$ | 39,8% | — | — | — |
| 2020-12-31 | 14,5 T US$ | 7,2 T US$ | 5,6 T US$ | 6,1 T US$ | 5,5 T US$ | 649 Tr US$ | 992 Tr US$ | 224 Tr US$ | 2,6 T US$ | 3,4 T US$ | — | -922 Tr US$ | -4,5 T US$ | 2,4 T US$ | 3,1 T US$ | 6,6 T US$ | 6,8 T US$ | 40,8% | — | — | — |
| 2021-12-31 | 18,3 T US$ | 10,1 T US$ | 7,8 T US$ | 8,8 T US$ | 6,3 T US$ | 2,5 T US$ | 954 Tr US$ | 230 Tr US$ | 527 Tr US$ | 3,9 T US$ | — | -4,1 T US$ | -3,1 T US$ | 3,1 T US$ | 4,6 T US$ | 9,7 T US$ | 7,7 T US$ | 48,8% | — | 6,7% | — |
| 2022-12-31 | 20 T US$ | 11,2 T US$ | 8,7 T US$ | 8,7 T US$ | 5,9 T US$ | 2,8 T US$ | 979 Tr US$ | 289 Tr US$ | 3,6 T US$ | 4,3 T US$ | 994 Tr US$ | -3,6 T US$ | -6,7 T US$ | 4,6 T US$ | 3,1 T US$ | 9,1 T US$ | 8,7 T US$ | 50,6% | — | 8,9% | — |
| 2023-12-31 | 17,5 T US$ | 8,5 T US$ | 6,5 T US$ | 6,4 T US$ | 1,3 T US$ | 5,1 T US$ | 1,2 T US$ | 362 Tr US$ | 293 Tr US$ | 4,6 T US$ | 2,5 T US$ | -4,4 T US$ | -2,1 T US$ | 3,1 T US$ | 3 T US$ | 8,6 T US$ | 11,2 T US$ | 41,8% | — | 8,8% | — |
| 2024-12-31 | 15,6 T US$ | 7,5 T US$ | 4,8 T US$ | 6,3 T US$ | 1,5 T US$ | 4,8 T US$ | 1,6 T US$ | 387 Tr US$ | 929 Tr US$ | 4,8 T US$ | 2,4 T US$ | -3,2 T US$ | -2,9 T US$ | 3 T US$ | 3,2 T US$ | 7,6 T US$ | 13,6 T US$ | 34,9% | — | 9,3% | — |
| 2025-12-31 | 17,7 T US$ | 8,3 T US$ | 5 T US$ | 7,2 T US$ | 2,6 T US$ | 4,6 T US$ | 2 T US$ | 419 Tr US$ | 1,5 T US$ | 5 T US$ | 449 Tr US$ | -1,4 T US$ | -5,7 T US$ | 3,2 T US$ | 3,2 T US$ | 4,9 T US$ | 14 T US$ | 34,1% | — | 9,1% | — |
Texas Instruments Incorporated (TXN) trades at 26.1x forward earnings against a peer median of 16.6x. Its EV/EBITDA of 25.6x compares with a peer median of 21.1x. The comparison uses 4 peers: QUALCOMM Incorporated, Analog Devices Inc., Microchip Technology Incorporated and NXP Semiconductors N.V., as of 2026-09-08 to 2026-09-09.
Company capex declined from $5.07 billion in FY2023 to $4.55 billion in FY2025. Industry benchmarks were 4.4% of revenue and 1.27x depreciation as of 2026-09-01.5
FY2027 analyst forecasts average $24.93 billion of revenue, supporting a demand-led recovery if customers rebuild orders and Analog participates.
The FY2027 revenue range of $22.8 billion to $29.60 billion shows that recovery strength remains uncertain. A demand pause would leave added manufacturing capacity underused.
Analog produced $14.01 billion of FY2025 revenue. Its demand path therefore determines whether consolidated recovery absorbs the manufacturing cost base.6
No new allocation. The report-date price of $258.92 exceeds Potential value of $137.20, so new exposure is not supported.3
Treat customer loss, persistent sub-30% margin, and failed capital normalization as exit signals rather than temporary volatility.
The report-date price is above Potential value, despite a plausible earnings recovery.3
FY2025 free cash flow remained sensitive to elevated capital spending, limiting support for paying the report-date valuation.45
Reduce on recovery-driven strength rather than relying on the valuation premium to persist.3
Sell because the report-date price materially exceeds Fair value and Potential value.3
The FY2027 revenue forecast supports a recovery from FY2025, but Fair value remains below the report-date price. Upside still requires capital spending to produce stronger free cash flow.
Capture your own thesis, position size, and follow-up questions. Stays on this device, only you can see it.
The records this analysis drew on, as they stood when it was run.
Not every cited input appears here: internal calculations and intermediate model outputs have no external record, and some citations could not be matched to one.
If WACC exceeds 11.8508%, distant recovery cash flows lose value before earnings can close the valuation gap.2
Excess spending would keep reinvestment high after the planned normalization period, delaying stronger cash generation and weakening dividend support per share.
Hiện tại:Approximately 2.28x in FY2025
Cảnh báo nếuAbove 1.5x in FY2030
A higher hurdle rate would reduce the present worth of distant cash flows before operating improvement can close the valuation gap.
Hiện tại:9.8508% as of 2026-09-09
Cảnh báo nếuAbove 11.8508% within 12 months
A customer cut would reduce sales immediately and leave factory costs spread across fewer units, lowering margins, earnings and cash.
Hiện tại:12% of FY2025 revenue
Cảnh báo nếuA reported loss, material repricing, or in-sourcing event
Sustained Analog contraction, without offsetting growth elsewhere, would reduce consolidated sales and leave less revenue to absorb factory costs, lowering operating profit and free cash flow.
Hiện tại:$14.01 billion of FY2025 revenue
Cảnh báo nếuBelow 0% for two consecutive fiscal years through FY2029
Convert the revenue and margin path into after-tax free cash flow, discount the annual per-share amounts and terminal value at WACC, then adjust for signed net debt per current share.
Add depreciation to net income, subtract maintenance capex, divide by diluted shares, and apply a normalized valuation multiple.
Discount the explicit dividend path and its Gordon-growth terminal value at cost of equity.
Limitation: Terminal value is 71.2% of this model's value, above the 60% level at which the methodology flags concentration; the value leans on the years beyond the explicit forecast.
Solve for the growth rate that makes the model value equal the report-date share price.
This path raises profit and cash without requiring investors to pay a higher valuation for each dollar of earnings. Persistent heavy reinvestment would disconfirm it.
A weak margin would signal poor utilization or pricing.5
A purchase cut would hurt sales and utilization.6
| FY2035 |
|---|
| Revenue | $21.87B | $24.89B | $26.61B | $27.94B | $29.09B | $30.14B | $31.11B | $32.02B | $32.90B | $33.76B |
| Revenue growth | 23.7% | 13.8% | 6.9% | 5.0% | 4.1% | 3.6% | 3.2% | 2.9% | 2.8% | 2.6% |
| Operating margin | 34.2% | 35.4% | 36.2% | 36.9% | 36.9% | 37.0% | 37.0% | 37.1% | 37.1% | 37.2% |
| Operating income | $7.48B | $8.82B | $9.62B | $10.30B | $10.74B | $11.15B | $11.52B | $11.88B | $12.22B | $12.54B |
| Tax rate | 12.2% | 12.2% | 12.2% | 12.2% | 12.2% | 12.2% | 12.2% | 12.2% | 12.2% | 12.2% |
| NOPAT | $6.56B | $7.75B | $8.45B | $9.04B | $9.43B | $9.79B | $10.12B | $10.42B | $10.72B | $11.01B |
| Reinvestment | $2.53B | $2.24B | $1.63B | $872.24M | $0.00 | $276.80M | $572.12M | $884.42M | $1.21B | $1.56B |
| Reinvestment rate (of NOPAT) | 38.6% | 29.0% | 19.3% | 9.7% | 0.0% | 2.8% | 5.7% | 8.5% | 11.3% | 14.1% |
| Depreciation and amortization | $2.47B | $2.81B | $3.01B | $3.16B | $3.29B | $3.41B | $3.52B | $3.62B | $3.72B | $3.82B |
| Free cash flow to firm | $4.03B | $5.50B | $6.82B | $8.17B | $9.43B | $9.51B | $9.54B | $9.54B | $9.51B | $9.45B |
| Analog revenue | $17.32B | $19.72B | $21.08B | $22.13B | $23.04B | $23.88B | $24.64B | $25.36B | $26.06B | $26.74B |
| Embedded Processing revenue | $3.34B | $3.80B | $4.06B | $4.26B | $4.44B | $4.60B | $4.74B | $4.88B | $5.02B | $5.15B |
| All Other Segments revenue | $1.21B | $1.38B | $1.47B | $1.55B | $1.61B | $1.67B | $1.72B | $1.77B | $1.82B | $1.87B |
| Terminal growth | 2.5% | 2.5% | 2.5% | 2.5% | 2.5% | 2.5% | 2.5% | 2.5% | 2.5% | 2.5% |
| Biên |
|---|
| TXN | Texas Instruments Incorporated | $236.5B | 26.1x | 12.2x | 25.6x | 35.2% | — |
| QCOM | QUALCOMM Incorporated | 17.0x | 4.2x | 15.8x | 33.8% | 18.5% | |
| ADI | Analog Devices Inc. | 22.2x | 12.7x | 26.4x | 12.2% | 39.5% | |
| MCHP | Microchip Technology Incorporated | 16.1x | 7.8x | 29.9x | 7.2% | 24.0% | |
| NXPI | NXP Semiconductors N.V. | 12.4x | 4.3x | 12.7x | 27.9% | 30.4% |